1 result(s) for
|PI Name||Protocol #||Title|
|Arpita Gandhi||STUDY00021456||A Phase 1/2 Study to Evaluate the Safety and Efficacy of JSP191 in Combination with a Reduced Intensity Conditioning Regimen of Low Dose Radiation and Fludarabine in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)|
You may also qualify for Phase 1 Program trials.
For more information: